期刊
OPHTHALMIC SURGERY LASERS & IMAGING RETINA
卷 49, 期 5, 页码 313-319出版社
SLACK INC
DOI: 10.3928/23258160-20180501-04
关键词
-
资金
- NIH Center Core Grant [P30EY014801]
- Research to Prevent Blindness
- Research to Prevent Blindness Unrestricted Grant
BACKGROUND AND OBJECTIVE: To report the incidence rates, causative organisms, and visual acuity (VA) outcomes in patients with endophthalmitis associated with intravitreal injection of anti-vascular endothelial growth factor inhibitors. PATIENTS AND METHODS: Retrospective case series between 2005 and 2017. RESULTS: The study included 39 eyes of 39 patients, including 27 (69%) referred and 12 (31%) institutional patients. The use of topical antibiotics after an injection was gradually phased out at the authors' institution, where the preinjection rate of all clinically suspected endophthalmitis was 0.013% (24 of 183,898). The most common isolates were coagulase-negative Staphylococcus and Streptococcus, A VA of 5/200 or better was achieved in 21 of 39 eyes (54%) overall and in two of 15 eyes (13%) infected with Streptococcus. CONCLUSIONS: The rate of post-intravitreal injection endophthalmitis is low. Outcomes were generally poor, and the worst wore associated with Streptococcus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据